Wasatch Advisors Inc Macrogenics Inc Transaction History
Wasatch Advisors Inc
- $17.6 Billion
- Q1 2025
A detailed history of Wasatch Advisors Inc transactions in Macrogenics Inc stock. As of the latest transaction made, Wasatch Advisors Inc holds 3,250,248 shares of MGNX stock, worth $5.66 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,250,248
Previous 3,488,493
6.83%
Holding current value
$5.66 Million
Previous $11.3 Million
63.6%
% of portfolio
0.02%
Previous 0.06%
Shares
32 transactions
Others Institutions Holding MGNX
# of Institutions
133Shares Held
54MCall Options Held
45.1KPut Options Held
143K-
Bellevue Group Ag Kuesnacht, V89.93MShares$17.3 Million0.29% of portfolio
-
Armistice Capital, LLC New York, NY6.3MShares$11 Million0.12% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$9.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.43MShares$7.7 Million0.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.18MShares$5.53 Million0.25% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $107M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...